Lucid Diagnostics Receives Nasdaq Notice for Failing Minimum Bid Price Requirement
Lucid Diagnostics received a Nasdaq noncompliance notice on October 12, 2026, for breaching Listing Rule 5550(a)(2)'s $1 minimum bid price requirement. Common stock closed below $1 for 30 consecutive business days through October 9, 2026; the compliance deadline is April 12, 2027. The initial compliance period spans 18